Abstract The reggies/flotillins are oligomeric scaffolding proteins for membrane microdomains. We show here that reggie-1/flotillin-2 microdomains are organized along cortical F-actin in several cell types. Interaction with F-actin is mediated by the SPFH domain as shown by in vivo co-localization and in vitro binding experiments. Reggie-1/flotillin-2 microdomains form independent of actin, but disruption or stabilization of the actin cytoskeleton modulate the lateral mobility of reggie-1/flotillin-2 as shown by FRAP. Furthermore, reggie/flotillin microdomains can efficiently be immobilized by actin polymerisation, while exchange of reggie-1/flotillin-2 molecules between microdomains is enhanced by actin disruption as shown by tracking of individual microdomains using TIRF microscopy.
Introduction
It is generally accepted that the plasma membrane of eukaryotic cells is organized into microdomains conveying specificity to membrane-associated processes. Although the existence of membrane microdomains based solely on phase separation of lipids (''lipid rafts'') is presently under intense scrutiny [1] , the existence of membrane microdomains organized and scaffolded by oligomeric proteins like caveolins is indisputable [2] . Reggie-1 and -2 were discovered as proteins upregulated in retinal ganglion cells during axon regeneration after optic nerve injury [3] . They were independently described as proteins abundant in the ''floating'' detergent-resistant membrane fraction and therefore named flotillin-2 and -1, respectively [4] . The reggies/flotillins oligomerize at cellular membranes [5, 6] to form clusters of approximately 50-100 nm [7, 8] . These clusters form the scaffold of specialized membrane microdomains implicated in insulin signalling [9] , lymphocyte activation [10] and endocytosis of GPI-anchored proteins [11] (reviewed in [12] ). It is generally assumed that plasma membrane microdomains are anchored to the actin cytoskeleton but experimental evidence is scarce. Only for caveolae an indirect interaction of caveolin-1 with actin via filamin has been shown [13] , for most other microdomains the anchoring mechanism is unclear. Here, we provide evidence for an interaction of reggie-1/flotillin-2 with F-actin, which is mediated by its SPFH domain and regulates its lateral mobility at the plasma membrane and thus positioning and local stabilization of reggie/flotillin microdomains.
Material and methods

Antibodies, plasmids and reagents, cells and transfection
Anti-actin polyclonal antibody (pAB) was from Santa Cruz (Santa Cruz, USA), anti-GST pAB from Amersham Pharmacia (Piscataway, USA), anti-reggie-1/flotillin-2 mAB from Transduction Labs (Heidelberg, Germany), phalloidin-Alexa-568 from Molecular Probes (Leiden, Netherlands), secondary antibodies coupled to HRP from Jackson ImmunoResearch (Soham, UK). Cytochalasin D and Jasplakinolide were from Calbiochem (Bad Soden, Germany). a-Actin was from Sigma (Munich, Germany), b-actin from Cytoskeleton (Denver, USA). Enzymes for molecular biology were from New England Biolabs (Beverly, USA) or Fermentas (St. Leon-Rot, Germany). Deletion mutants of reggie-1 were obtained by PCR using rat full-length reggie-1 cloned in pEGFP-N1 (Clontech, Heidelberg, Germany) (R1FL-EGFP) as template [5] and primers introducing restriction sites for EcoRI and BamHI. Fragments were then subcloned into pEGFP-N1. N2a and HeLa cells were cultured and transfected as described previously [14] .
Microscopy
For immunofluorescence, cells were grown on poly-L L-lysine coated coverslips (VWR, Darmstadt, Germany), fixed with 4% paraformaldehyde, permeabilized by brief immersion in 0.1% Triton-X100 (Sigma) and incubated with phalloidin as indicated. For TIRF microscopy the TIRF slider system and a a-Plan Fluar 100·/1.45 objective from Carl Zeiss were used in combination with an Axiovert 200M and an Axiocam MRm (all Carl Zeiss). Images were analysed and processed using Axiovision 4.6 (Carl Zeiss) and ImageJ [15] . For tracking of individual microdomains, the feature point tracking algorithm [16] integrated in an ImageJ plugin was used [17] . FRAP experiments were carried out on a LSM 510 META using a 63·/1.4 Plan-Apochromat objective as described previously [10] .
Electron microscopy
N2a cells were treated with 1 lM Cytochalasin D as indicated and processed for immuno-gold electron microscopy as described previously [7, 18] .
In vitro actin binding assay
DR1NT, the isolated SPFH domain of reggie-1/flotillin-2, was amplified by PCR using pR1FL-EGFP as template and subcloned into pQE31 (Qiagen) and pGEX (Amersham) for N-terminally tagging with a His 6 -and a GST-tag, respectively. The fusion protein was expressed in Escherichia coli BL21(DE)pLysS and purified according to the instructions provided by the vector's manufacturers. Actin binding was assayed by co-precipitation with F-actin. Briefly, a-or b-actin stock solution in G-actin buffer (200 lM CaCl 2 , 200 lM ATP, 100 lM DTT, 5 mM Tris, pH 8) were mixed with polymerisation buffer (100 mM KCl, 2 mM MgCl 2 , 1 mM EGTA, 1 mM ATP, 5 mM Tris, pH 7.5) and incubated for 1 h at room temperature. The indicated amount of protein was added and incubated for 1 h at room temperature. The mixture was centrifuged for 1 h at 100 000 · g and 4°C in a Beckmann Optima MaxE ultracentrifuge using a TLA 55 rotor. The supernatant was mixed with 5· sample buffer, the pellets were washed once in buffer, recentrifuged and solubilized in 2· sample buffer. Samples were analysed by SDS-gel electrophoresis, Coomassie blue or Western blotting. Actin polymerisation was assayed using the Actin Polymerisation Biochem Kit (Cytoskeleton) and a Spectrofluor Plus 96-well plate reader (Tecan, Zurich, Switzerland) according to the manufacturer's protocols.
Results and discussion
Reggie-1/flotillin-2 associates with filamentous actin in cells
Reggie-1/flotillin-2 fused to EGFP (R1FL-EGFP) clearly colocalized with phalloidin-stained F-actin at the plasma membrane of N2a (Fig. 1B) , HeLa, HepG2 and 3T3 cells (data not shown). Reggie-1/flotillin-2 microdomains at the plasma membrane were organized along actin filaments of the membrane cytoskeleton (Fig. 1B) . Identical results were obtained with HA-tagged reggie-1/flotillin-2, and no co-localization of reggie-1/flotillin-2 with microtubuli or vimentin-type intermediate filaments could be observed (data not shown). Endogenous reggie-1/flotillin-2 also co-localized with F-actin ( Supplementary Fig. 1A ), but to a small extent only. This difference is most probably caused by the incompatible fixation procedures for F-actin recovery and reggie-1/flotillin-2 staining. Overexpressed reggie-1/flotillin-2, however, did no longer associate into microdomains, but localized along F-actin fibres ( Supplementary Fig. 1B ), corroborating the inherent ability of reggie-1/flotillin-2 to interact with F-actin. We tried to exclude fixation artefacts by live cell imaging of N2a cells expressing actin-mRFP and R1FL-EGFP, but the diffuse background caused by G-actin-mRFP excluded clear co-localization analysis ( Supplementary Fig. 1C ). Co-localization with F-actin was previously also shown for other members of the SPFH family, i.e. stomatin-1 [19] or podocin [20] .
Using different deletion constructs we next identified the reggie-1/flotillin-2 domains involved in actin interaction. R1NT-EGFP comprising the SPFH domain (Fig. 1A) localized to the plasma membrane. Microdomain/cluster formation was, however, less pronounced as this construct lacks the flotillin domain known to mediate oligomerization [6] . R1NT-EGFP localized along F-actin fibres (Fig. 1C) , demonstrating that the flotillin domain is dispensable for association with F-actin. The membrane anchor region alone (aa 1-30) also localized to the plasma membrane (although it accumulated at the Golgi complex to some extent), but its distribution at the plasma membrane was diffuse and showed no correlation with the underlying membrane cytoskeleton (Fig. 1D) . Similarly, R1MCT, a construct lacking the SPFH domain (Fig. 1A) showed diffuse localization at the plasma membrane without association with F-actin (Fig. 1E) . Thus, the SPFH domain is apparently necessary for the association of reggie-1/flotillin-2 with F-actin at the plasma membrane.
3.2. In vitro binding of the SPFH domain of reggie-1/flotillin-2 to F-actin To investigate whether the co-localization of R1FL-EGFP with F-actin observed in vivo is the result of a direct interaction of reggie-1/flotillin-2 with F-actin, we purified the minimal actin binding domain identified above (DR1NT, Fig. 2A ) as a His-or GST-tagged protein recombinantly expressed in E. coli and tested its ability to bind to actin in vitro by co-precipitation with F-actin. Both the His-tagged and the GST-tagged DR1NT, but not BSA as negative control (data not shown), co-precipitated specifically with filamentous a-and b-actin but not with G-actin or the respective buffer controls (Fig. 2B) . Thus, the SPFH domain of reggie-1/flotillin-2 is capable of binding to F-actin. However, DR1NT had no discernible effect on the kinetics of in vitro actin polymerisation assayed by pyrene-actin fluorescence (Fig. 2C) , suggesting that binding of reggie-1/flotillin-2 to F-actin mediates anchoring only. Most interestingly, actin-binding might be a general function of the SPFH-domain to which so far no general function was assigned.
3.3. Reggie-1/flotillin-2 microdomains are formed by oligomerization rather than by binding to actin To test whether reggie/flotillin microdomains are formed by interaction of reggie-1/flotillin-2 with the cortical actin cytoskeleton, we treated N2a cells with Cytochalasin D to destroy the actin cytoskeleton, which we verified by phalloidin-staining and fluorescence microscopy (data not shown). We then analysed the localization of reggie-1/flotillin-2 in Cytochalasin D-treated vs. non-treated control cells by immuno-gold labelling and electron microscopy. In both control and CytD-treated cells, numerous reggie/flotillin clusters were observed (Fig. 3A) and no significant difference in number, size or frequency of reggie/flotillin microdomains (Fig. 3B) was observed, suggesting that reggie/flotillin microdomains are most probably formed by oligomerization of the reggies/flotillins rather than by clustering via binding to the cortical actin cytoskeleton.
Interaction with F-actin regulates the lateral mobility of
reggie-1/flotillin-2 Next, we investigated the influence of the actin cytoskeleton on the lateral mobility of reggie-1/flotillin-2 by fluorescence recovery after photobleaching (FRAP) in N2a cells. A mobile fraction of 0.83 ± 0.02 (n = 25, ±S.E.M.) and a half time of fluorescence recovery of only t 1/2 = 16.2 ± 1.6 s indicated high lateral mobility of R1FL-EGFP in N2a cells (Fig. 4A) as previously reported for PC12 and Jurkat cells [10] . Disruption of the actin cytoskeleton by Cytochalasin D treatment significantly decreased the half time of fluorescence recovery to t 1/2 = 11.1 ± 1.5 s (n = 25), while having no significant influence on the mobile fraction (M F = 0.80 ± 0.02) (Fig. 4A and  B) . This suggests that a breakdown of the actin cytoskeleton increases the lateral mobility of reggie-1/flotillin-2. Incubation with Jasplakinolide, an actin stabilizing compound [21] , significantly increased the half time of fluorescence recovery to t 1/2 = 20.2 ± 1.5 s (n = 30) ( Fig. 4A and B) . Thus actin stabilization reduced the lateral mobility of reggie-1/flotillin-2.
The reggies/flotillins are associated with the detergent-resistant membrane fraction. Therefore, we tested the role of cholesterol on the mobility of the reggies/flotillins. Cholesterol depletion using methyl-b-cyclodextrin led to a significant reduction of reggie-1/flotillin-2 mobility at the plasma membrane (Fig. 4B) as shown before for a variety of other membrane proteins [22] , thus confirming the sensitivity and validity of our FRAP approach. Disruption of microtubules by nocodazole was without effect on reggie-1/flotillin-2 mobility (Fig. 4B) .
To test whether the observed effects of actin on reggie-1/flotillin-2-mobility were caused by molecular interactions between reggie-1/flotillin-2 and F-actin or by an indirect, general effect of an actin-anchored picket fence on membrane protein mobility, we performed similar experiments with the deletion mutant R1MCT. R1MCT has the same membrane anchor as the wildtype protein, but lacks most of the SPFH domain which is necessary for actin interaction (Fig. 1A) . FRAP experiments in untreated control cells showed a generally faster lateral diffusion of R1MCT compared with the full length protein (t 1/2 = 6.9 ± 0.7 s, (n = 26)) ( Fig. 4C and D) . Jasplakinolidetreatment had no effect on the lateral mobility of R1MCT (t 1/2 = 6.7 ± 0.7 s, (n = 30)) ( Fig. 4C and D) . Thus, R1MCT mobility is unaffected by F-actin stabilization, confirming that the lateral diffusion of full-length reggie-1/flotillin-2 is regulated by interaction of its SPFH domain with F-actin.
3.5. Reggie-1/flotillin-2 microdomains can be trapped by F-actin stabilization The changes in reggie-1/flotillin-2 mobility observed in FRAP experiments might be caused by changes in mobility of reggie-1/flotillin-2 microdomains at the plasma membrane or by modulation of exchange of individual molecules between microdomains. We therefore measured the mobility of reggie/ flotillin microdomains directly by total internal reflection fluorescence (TIRF) microscopy. We used HeLa cells in these experiments, because reggie-1/flotillin-2 microdomains are less densely spaced in these cells (Fig. 5A) , so that individual microdomains can be unambiguously followed. The general lateral mobility of reggie-1/flotillin-2 and its dependence on actin as observed by FRAP experiments in HeLa cells is similar to N2a cells (data not shown).
Reggie-1/flotillin-2 microdomains at the plasma membrane of HeLa cells exhibited a biphasic diffusional behaviour. Phases of confined diffusion (Fig. 5B, pictures 1,2 and 4 ,5) were interrupted by phases of long range diffusion (Fig. 5B,  pictures 3 and 6 ). This behaviour is reminiscent of the hop-diffusion in lateral confinement zones observed in single molecule studies [23] .
Neither stabilization of the actin cytoskeleton by Jasplakinolide nor disruption by Cytochalasin D changed the steady state number or appearance of reggie-1/flotillin-2 microdomains as observed by TIRF microscopy, confirming our results by electron microscopy (Fig. 3) . Disruption of F-actin by Cytochalasin D had no effect on the lateral mobility of reggie-1/flotillin-2 microdomain mobility. Diffusional behaviour was indistinguishable from untreated control cells (Fig. 5C) , suggesting that the increased mobility observed in FRAP experiments is caused by increased exchange of individual molecules between clusters. This is further corroborated by the observation, that in Cytochalasin D-treated cells many tracks of individual microdomains were lost, because their fluorescent signal became diffuse, suggesting lateral dispersion of the molecules. Thus, interaction with F-actin might regulate the exchange of reggie-1/flotillin-2 molecules and potentially proteins bound to reggie-1/flotillin-2 between individual microdomains.
Stabilization of the actin cytoskeleton by Jasplakinolidetreatment significantly decreased the lateral mobility of reggie-1/flotillin-2 microdomains. The mean displacement in Jasplakinolide-treated cells was significantly lower compared with untreated control cells (Fig. 5C ). Many microdomains were almost completely immobilized and phases of long-range diffusion were very rare (Fig. 5D) . Thus, by local stabilization of the cortical actin cytoskeleton, cells can efficiently immobilize reggie-1/flotillin-2 microdomains. We have previously described a dramatic immobilization of reggie/flotillin microdomains in T lymphocytes, where many reggie/flotillin microdomains are pre-assembled in a polarized macrodomain, which is stabilized by the actin cytoskeleton [10] .
In summary, our results unravel the anchoring of reggie-1/ flotillin-2 microdomains to the cortical actin cytoskeleton by binding of its SPFH domain to F-actin. This mechanism may apply also to other membrane microdomains scaffolded by SPFH-proteins like stomatins, podocin, erlins or prohibitin.
This provides a mechanism ensuring spatial specificity in pathways depending on these different microdomains, as cells can restrict and steer lateral diffusion of these microdomains simply by regulation of actin dynamics.
